GlyBURIDE-Metformin Information

What's inside GlyBURIDE-Metformin

GlyBURIDE-Metformin in the News

ADOPT analysis shows rosiglitazone increases risk of fracture in women - TheHeart.Org
Chicago, IL - Not unlike a prizefighter battered and bruised, rosiglitazone (Avandia, GlaxoSmithKline) continued to take it on the chin this week, ...
Fri Jun 29 12:15:09 -0400 2007

Nip diabetes in the bud - New Straits Times
By : Manveet Kaur. Diabetes can’t be cured but it is essential to slow its progression. MANVEET KAUR reports on a new type of medication in the market. ...
Mon Apr 23 20:44:40 -0400 2007

Anti-diabetes drug slows progressive loss of sugar control in ... - exduco.net
The anti-diabetes drug, rosiglitazone, significantly slowed the increase of blood sugar levels in patients with recently diagnosed type 2 diabetes, ...
Fri Apr 20 03:08:43 -0400 2007

GlyBURIDE-Metformin Chemical Information

glyburide - A member of the second generation of the sulfonylurea hypoglycemic agents. Glyburide inhibits the ATP-sensitive potassium channels on the beta-cell membrane, thereby preventing potassium efflux leading to membrane depolarization and subsequent calcium influx. The increased intracellular levels of calcium induce insulin secretion from functioning beta-cells of the pancreatic islet tissue and leads to a lowering in blood glucose levels.

metformin hydrochloride - The hydrochloride salt form of metformin, a biguanide with antihyperglycemic activity. Metformin hydrochloride exerts its action by improving hepatic sensitivity to insulin, thereby suppressing hepatic glucose production and increasing hepatic glycogen stores. In addition, metformin hydrochloride increases the number and/or affinity of insulin receptors on cell surface membranes in muscle and adipose tissue, thereby increasing the sensitivity to insulin at receptor and post-receptor binding sites and increasing glucose uptake peripherally.